Action of PCSK9 inhibitor on LDL receptor

Bildnummer 11722831
Action of PCSK9 inhibitor on LDL receptor
Computer illustration showing the action of a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor antibody (green) on the degradation of a low-density lipoprotein molecule (LDL,round) and LDL receptor (LDLR,orange) when bound to a PCSK9 enzyme molecule (blue). When there are high levels of LDL cholesterol in the blood it builds up on the sides of blood vessels hardening them,a condition named atherosclerosis. This narrows the blood vessels and may block them. LDL receptors in cell membranes recognise and bind (upper left) to LDL molecules to remove them from the bloodstream. When PCSK9 binds to an LDLR,the receptor and LDL particle are absorbed by the cell and destroyed. However,if PCSK9 does not bind,only the LDL particle is destroyed (lower left) and the receptor can return to the surface of the cell (right) and remove more cholesterol. Monoclonal antibodies that bind to and inhibit PCSK9 are being used to reduce the amount of cholesterol in the blood by improving the liver's ability to recycle LDLRs
Lizenzart: Lizenzpflichtig
Credit: Science Photo Library / De Angelis, Maurizio
Bildgröße: 5000 px × 3750 px
Modell-Rechte: nicht erforderlich
Eigentums-Rechte: nicht erforderlich
Restrictions: -

Preise für dieses Bild ab 15 €

Universitäten & Organisationen
(Informationsmaterial Digital, Informationsmaterial Print, Lehrmaterial Digital etc.)
ab 15 €
Redaktionell
(Bücher, Bücher: Sach- und Fachliteratur, Digitale Medien (redaktionell) etc.)
ab 30 €
Werbung
(Anzeigen, Aussenwerbung, Digitale Medien, Fernsehwerbung, Karten, Werbemittel, Zeitschriften etc.)
ab 55 €
Handelsprodukte
(bedruckte Textilie, Kalender, Postkarte, Grußkarte, Verpackung etc.)
ab 75 €
Pauschalpreise
Rechtepakete für die unbeschränkte Bildnutzung in Print oder Online
ab 495 €

Keywords

;